Article Details

Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of "Buy" from Brokerages

Retrieved on: 2020-12-12 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of "Buy" from Brokerages. View article details on hiswai:

Excerpt

The <b>biotechnology</b> company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.28 by $0.12. The business had revenue of ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up